AZD2171, a Pan-VEGF Receptor Tyrosine Kinase Inhibitor, Normalizes Tumor Vasculature and Alleviates Edema in Glioblastoma Patients
Titel:
AZD2171, a Pan-VEGF Receptor Tyrosine Kinase Inhibitor, Normalizes Tumor Vasculature and Alleviates Edema in Glioblastoma Patients
Auteur:
Batchelor, Tracy T. Sorensen, A. Gregory di Tomaso, Emmanuelle Zhang, Wei-Ting Duda, Dan G. Cohen, Kenneth S. Kozak, Kevin R. Cahill, Daniel P. Chen, Poe-Jou Zhu, Mingwang Ancukiewicz, Marek Mrugala, Maciej M. Plotkin, Scott Drappatz, Jan Louis, David N. Ivy, Percy Scadden, David T. Benner, Thomas Loeffler, Jay S. Wen, Patrick Y. Jain, Rakesh K.